In conclusion, the present pilot data suggest KLF11 promoter hypomethylation as a potential epigenetic marker of MDD comorbidity in PD or non-anxious depression, respectively, possibly contributing to a differential pathomechanism of anxiety and mood disorders. The gene discussed is KLF11; the disease is mood disorder.